302 related articles for article (PubMed ID: 1332587)
21. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo evaluations of A-80556, a new fluoroquinolone.
Clement JJ; Tanaka SK; Alder J; Vojtko C; Beyer J; Hensey D; Ramer N; McDaniel D; Chu DT
Antimicrob Agents Chemother; 1994 May; 38(5):1071-8. PubMed ID: 8067740
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo antibacterial efficacies of CFC-222, a new fluoroquinolone.
Kim JH; Kang JA; Kim YG; Kim JW; Lee JH; Choi EC; Kim BK
Antimicrob Agents Chemother; 1997 Oct; 41(10):2209-13. PubMed ID: 9333049
[TBL] [Abstract][Full Text] [Related]
24. [Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002].
Matsuzaki K; Watabe E; Yoshimori K; Shikano M; Sato Y; Hasegawa M; Kobayashi I
Jpn J Antibiot; 2002 Dec; 55(6):800-7. PubMed ID: 12621734
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial activity of CS-940, a new trifluorinated quinolone.
Biedenbach DJ; Sutton LD; Jones RN
Antimicrob Agents Chemother; 1995 Oct; 39(10):2325-30. PubMed ID: 8619590
[TBL] [Abstract][Full Text] [Related]
26. In-vitro and in-vivo activities of DW-116, a new fluoroquinolone.
Choi KH; Hong JS; Kim SK; Lee DK; Yoon SJ; Choi EC
J Antimicrob Chemother; 1997 Apr; 39(4):509-14. PubMed ID: 9145824
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116.
Imada T; Miyazaki S; Nishida M; Yamaguchi K; Goto S
Antimicrob Agents Chemother; 1992 Mar; 36(3):573-9. PubMed ID: 1320364
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of T-3761, a new fluoroquinolone.
Muratani T; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1992 Oct; 36(10):2293-303. PubMed ID: 1332594
[TBL] [Abstract][Full Text] [Related]
29. E-4695, a new C-7 azetidinyl fluoronaphthyridine with enhanced activity against gram-positive and anaerobic pathogens.
Guinea J; Gargallo-Viola D; Robert M; Tudela E; Xicota MA; Garcia J; Esteve M; Coll R; Pares M; Roser R
Antimicrob Agents Chemother; 1995 Feb; 39(2):413-21. PubMed ID: 7726507
[TBL] [Abstract][Full Text] [Related]
30. Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.
Yoshida T; Mitsuhashi S
Antimicrob Agents Chemother; 1993 Apr; 37(4):793-800. PubMed ID: 8388199
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of sparfloxacin compared with those of five other quinolones.
Cantón E; Pemán J; Jimenez MT; Ramón MS; Gobernado M
Antimicrob Agents Chemother; 1992 Mar; 36(3):558-65. PubMed ID: 1320362
[TBL] [Abstract][Full Text] [Related]
32. Activity of temafloxacin against respiratory pathogens.
Swanson RN; Hardy DJ; Chu DT; Shipkowitz NL; Clement JJ
Antimicrob Agents Chemother; 1991 Mar; 35(3):423-9. PubMed ID: 2039192
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin.
Fu KP; Lafredo SC; Foleno B; Isaacson DM; Barrett JF; Tobia AJ; Rosenthale ME
Antimicrob Agents Chemother; 1992 Apr; 36(4):860-6. PubMed ID: 1503449
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of OPC-17116.
Neu HC; Fang W; Gu JW; Chin NX
Antimicrob Agents Chemother; 1992 Jun; 36(6):1310-5. PubMed ID: 1329620
[TBL] [Abstract][Full Text] [Related]
35. In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Stamm JM; Hanson CW; Chu DT; Bailer R; Vojtko C; Fernandes PB
Antimicrob Agents Chemother; 1986 Feb; 29(2):193-200. PubMed ID: 3087274
[TBL] [Abstract][Full Text] [Related]
36. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
McCarter YS; Mazens-Sullivan MF; Bartlett RC
Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
[TBL] [Abstract][Full Text] [Related]
37. In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone.
Nilius AM; Shen LL; Hensey-Rudloff D; Almer LS; Beyer JM; Balli DJ; Cai Y; Flamm RK
Antimicrob Agents Chemother; 2003 Oct; 47(10):3260-9. PubMed ID: 14506039
[TBL] [Abstract][Full Text] [Related]
38. Antibacterial activities and pharmacokinetics of E-4767 and E-5065, two new 8-chlorofluoroquinolones with a 7-azetidin ring substituent.
Gargallo-Viola D; Ferrer S; Tudela E; Robert M; Coll R; Roser R; Guinea J
Antimicrob Agents Chemother; 2001 Nov; 45(11):3113-21. PubMed ID: 11600365
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone.
Takahata M; Mitsuyama J; Yamashiro Y; Yonezawa M; Araki H; Todo Y; Minami S; Watanabe Y; Narita H
Antimicrob Agents Chemother; 1999 May; 43(5):1077-84. PubMed ID: 10223917
[TBL] [Abstract][Full Text] [Related]
40. The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones.
Wise R; Brenwald NP; Andrews JM; Boswell F
J Antimicrob Chemother; 1997 Apr; 39(4):447-52. PubMed ID: 9145816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
